Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Current Ratio is 0.66 as of Feb. 2026, which is 3% below its 10-year median of 0.68. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 680 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 85.59% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. COSMOS Pharmaceutical's current ratio for the quarter that ended in Feb. 2026 was 0.66.
COSMOS Pharmaceutical has a current ratio of 0.66. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If COSMOS Pharmaceutical has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for COSMOS Pharmaceutical's Current Ratio or its related term are showing as below:
CSMYF'
s Current Ratio Range Over the Past 10 Years
Min: 0.59 Med: 0.68 Max: 0.78
Current: 0.66
During the past 13 years, COSMOS Pharmaceutical's highest Current Ratio was 0.78. The lowest was 0.59. And the median was 0.68.
CSMYF's Current Ratio is ranked worse than 85.59% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs CSMYF: 0.66
COSMOS Pharmaceutical (OTCPK:CSMYF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
COSMOS Pharmaceutical Current Ratio Related Terms
COSMOS Pharmaceutical Current Ratio Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Current Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Current Ratio distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Current Ratio of 0.66 as of Feb. 2026. This is near median its historical median of 0.68. Over the past decade, COSMOS Pharmaceutical's Current Ratio has ranged from 0.59 to 0.78. According to the industry distribution chart, COSMOS Pharmaceutical ranks #582 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 85.6%.
Is COSMOS Pharmaceutical's Current Ratio too high?
COSMOS Pharmaceutical's current Current Ratio of 0.66 is near median its 10-year median of 0.68. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 0.78. The Healthcare Providers & Services industry median Current Ratio is 1.47. COSMOS Pharmaceutical's value of 0.66 is 55.1% below this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #582 out of 680 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Current Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #582 out of 680 companies for Current Ratio. This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Current Ratio is 1.47. COSMOS Pharmaceutical's value of 0.66 is 55.1% below this benchmark. Historically, COSMOS Pharmaceutical's own Current Ratio has ranged from 0.59 to 0.78 over the past decade. While the company's 10-year median is 0.68 vs. the industry median of 1.47, COSMOS Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Current Ratio of 0.66 is 55.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Current Ratio is 0.66, which is near median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Current Ratio is 0.66, which is near median its 10-year median of 0.68 and 55.1% below the Healthcare Providers & Services industry median of 1.47. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Current Ratio is 0.66 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Current Ratio: 0.66 (near median its 10-year median of 0.68)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 55.1% below the Healthcare Providers & Services median (#582 of 680)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
